Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Health Policy topic
No spam. Unsubscribe anytime.
Council adopts resolution urging U.S. Congress to restore orphan‑drug tax credit in ‘Cameron’s Law’
Summary
The council unanimously passed a resolution urging federal legislators to restore the orphan‑drug tax credit to 50% to spur rare‑disease research, after a 16‑year‑old resident described her medical struggles and urged Nashville to support the bill.
The Metropolitan Council unanimously adopted a resolution supporting “Cameron’s Law,” a federal proposal to restore the orphan‑drug tax credit to 50% to incentivize pharmaceutical investment in rare‑disease treatments.
Councilmember Ewing presented the resolution on behalf of sponsor Councilmember Druffel (not present) and praised Ashley Massey, a 16‑year‑old Nashvillian who addressed council during public comment about her experience living with multiple rare diseases. Massey asked the council to urge Tennessee’s congressional delegation to back legislation that would increase the federal tax credit for orphan‑drug development from 25% back to 50%.
Ewing and other sponsors said the change would encourage pharmaceutical companies and research institutions to invest in therapies for rare conditions and could spur broader medical advances. Ewing noted the bill’s potential to draw national attention and asked Metro’s resolution to serve as a local statement urging members of Congress to act.
Action: The council adopted the nonbinding resolution supporting Cameron’s Law to accelerate rare disease innovation and research.
Ending: Sponsors said they hope the local resolution will prompt Tennessee’s representatives in Washington to sponsor or cosponsor the legislation and accelerate progress on treatments for rare diseases.
